Retinoic acid supplementation ameliorates motor incoordination via RARα-CBLN2 in the cerebellum of a prenatal valproic acid-exposed rat autism model.

Scientists studied motor problems in an autism rat model and found that vitamin A-related supplements improved movement coordination. The supplement helped restore normal brain development in the area that controls movement (cerebellum). This suggests vitamin A might help with movement difficulties that many autistic people experience.

This study investigated motor impairments in autism using a prenatal valproic acid (VPA) rat model. Researchers found that VPA-exposed offspring showed motor coordination problems and abnormal brain cell development in the cerebellum. The study identified decreased levels of retinoic acid (vitamin A derivative) and related proteins (RARα, CBLN2) in these animals. Importantly, retinoic acid supplementation restored motor coordination, normalized brain cell structure, and increased expression of key proteins.

The research suggests retinoic acid works through a specific pathway (RARα-CBLN2) in the cerebellum to improve motor function.

Results suggest retinoic acid supplementation might help address motor coordination difficulties in autism through cerebellar mechanisms. However, human trials are needed before clinical application. Findings support investigation of vitamin A metabolism in individuals with autism and motor impairments.

Animal model findings may not translate directly to humans. Sample size not reported, limiting assessment of statistical power. Single study requiring replication. Unclear if motor improvements would persist long-term or translate to other autism symptoms.

In addition to their core symptoms, most individuals with autism spectrum disorder (ASD) also experience motor impairments. These impairments are often linked to the cerebellum, which is the focus of the current study. Herein, we utilized a prenatal valproic acid (VPA)-induced rat model of autism and performed RNA sequencing in the cerebellum. Relative to control animals, the VPA-treated offspring demonstrated both abnormal motor coordination and impaired dendritic arborization of Purkinje cells (PCs).

Concurrently, we observed a decrease in the cerebellar expression of retinoic acid (RA) synthesis enzymes (RDH10, ALDH1A1), metabolic enzyme (CYP26A2), and lower levels of RA, retinoic acid receptor α (RARα), and Cerebellin2 (CBLN2) in the VPA-treated offspring. However, RA supplementation ameliorated these deficits, restoring motor coordination, normalizing PCs dendritic arborization, and increasing the expression of RA, RARα, and CBLN2. Further, ChIP assays confirmed that RA supplementation enhanced RARα's binding capacity to CBLN2 promoters. Collectively, these findings highlight the therapeutic potential of RA for treating motor incoordination in VPA-induced autism, acting through the RARα-CBLN2 pathway.